IMM 1.45% 34.0¢ immutep limited

Ann: Positive initial data in phase 2 Soft Tissue Sarcoma trial, page-8

  1. 2,588 Posts.
    lightbulb Created with Sketch. 1474
    "........... another positive set of responses ............"

    At what point does the market conclude de-risking is in the bag and value adding has really begun ? Surely IMM is now in that secondary phase !

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.